BiotechTube
Home/Optieum Biotechnologies/Kenji Nakamaru
KN

Kenji Nakamaru

Head of R&D, Vice President

Optieum Biotechnologies

Therapeutic Areas

OncologyImmunology

Optieum Biotechnologies Pipeline

DrugIndicationPhase
PROGRAM-1solid tumor, cancer associated fibroblastPre-Clinical
PROGRAM-2hematological malignancies, autoimmune disordersPre-Clinical
PROGRAM-3UndisclosedDiscovery

Leadership Team at Optieum Biotechnologies

SN
Shun Nishioka
President & CEO
DM
Dan MacLeod
Chief Scientific Officer
SC
Stewart Craig
Chief Technology Officer
TO
Toshiki Ochi
Scientific Founder, Co-Founder & Advisor
View full Optieum Biotechnologies profile